Quarterly shot could replace daily breast cancer pills
NCT ID NCT07401381
Summary
This study is testing a new quarterly injection of the hormone therapy drug letrozole to see if it gets into the bloodstream as well as the standard daily pill. It will involve 120 post-menopausal women who have already been treated for early-stage, hormone-positive breast cancer. The main goal is to compare the drug levels from the injection to the pill to see if they are similar.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.